Phase I study of the safety and acceptability of UC-781 topical vaginal microbicide in heterosexual women and their male partners
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2010
At a glance
- Drugs UC 781 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 12 Jan 2010 Actual end date (December 2008) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Nov 2005 New trial record.